Orthopedic technologies market seen reaching $98.14B by 2030

The global market for advanced orthopedic technologies, implants and regenerative products is projected to grow from $74.2 billion in 2026 to $98.14 billion by 2030, according to a new report from The Business Research Company. Rising sports injuries, robotic-assisted surgery and demand for patient-specific implants are among the main forces expected to drive growth.

Why it matters: - Advanced orthopedic products support faster recovery, better mobility and improved outcomes for patients with musculoskeletal conditions. - The market's projected rise signals growing demand for implants, biologics and regenerative therapies across surgery and rehabilitation. - Sports injuries, one of the report's key growth drivers, are rising alongside broader participation in physical activity.

What happened: - The Business Research Company released a report on the advanced orthopedic technologies, implants and regenerative products market covering 2026-2035. - The market is projected to grow from $69.58 billion in 2025 to $74.2 billion in 2026. - The report pegs the market at $98.14 billion by 2030. - The report forecasts a 6.6% CAGR in the historical period and a 7.2% CAGR over the forecast period. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.

The details: - Growth in the historical period is tied to rising musculoskeletal disorders, more orthopedic surgeries, better implant materials, specialty clinics and wider access to joint replacement procedures. - Forecast growth is linked to patient-specific implants, broader use of biologic therapies, higher investment in regenerative medicine research, more robotic-assisted surgeries and better long-term implant performance. - The report identifies regenerative therapies, smart implants, minimally invasive procedures and personalized orthopedic care as major trends. - A free sample of the report is available through the company's sample page. - The full report is available through the company's report page. - The market study covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

Between the lines: - The report points to a shift from conventional orthopedic care toward more personalized, tech-enabled treatment. - Rising sports injuries give the market a concrete demand base, while robotics and regenerative medicine expand the addressable opportunity. - The inclusion of market attractiveness scoring, TAM analysis and forecasting dashboards suggests buyers are looking for more granular planning tools, not just topline growth estimates.

What's next: - The market is expected to keep expanding as hospitals and device makers adopt smarter implants and regenerative solutions. - Asia-Pacific's growth trajectory will likely make it a more important target for suppliers over the forecast period. - Further investment in orthopedic robotics and biologic therapies could accelerate product innovation and adoption.

The bottom line: - Orthopedic care is moving toward more personalized, technology-driven treatment, and the market outlook remains strong through 2030.